Lisa Beck

24PUBLICATIONS
133CO-AUTHORS
Medical infection agents (incl. prions)Medical bacteriologyAllergyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Apr 18, 2026
Long-Term Dupilumab Treatment Is Not Associated with an Increased Overall Risk of Infections in Adults with Moderate-to-Severe Atopic Dermatitis: Results from an Open-Label 5-Year Extension Study.

|Dec 19, 2025
Observations on emergence of mannitol-use-deficient <i>Staphylococcus aureus</i>.

Patrick M Schlievert, Samuel H Kilgore, Takeshi Yoshida

|Oct 02, 2025
Population Pharmacokinetic and Pharmacodynamic Modeling for the Prediction of the Extended Amlitelimab Phase 3 Dosing Regimen in Atopic Dermatitis.

Gilles Tiraboschi, Kim Papp, Thomas Bieber

|Oct 25, 2024
The regulatory T cell-selective interleukin-2 receptor agonist rezpegaldesleukin in the treatment of inflammatory skin diseases: two randomized, double-blind, placebo-controlled phase 1b trials.

Jonathan I Silverberg, David Rosmarin, Raj Chovatiya

|Feb 15, 2024
Improved patient- and caregiver-reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis.

Julie Ryan Wolf, Anita Chen, Jill Wieser

|Nov 09, 2023
The vIGA-AD scale for atopic dermatitis: Uptake in the past 5 years and position of the International Eczema Council.

Robert Bissonnette, Eric Simpson, Lawrence F Eichenfield

Pageof 4

Frequent Collaborators

6 joint publications

Jonathan I Silverberg

5 joint publications

Mette Deleuran

4 joint publications

Matthew G Brewer

4 joint publications

Kim Papp